Novavax’s Nuvaxovid™ Receives Full Marketing Authorization in the EU for the Prevention of COVID
(Adnkronos) – GAITHERSBURG, Md., July 6, 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, has been granted full Marketing Authorization (MA) by
